Table 9.10b

Unadjusted Graft Survival, Living Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2003 - 2004) (Tx 2003 - 2004) (Tx 2001 - 2004) (Tx 1999 - 2004)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 639 90.0% 1.2% 639 84.0% 1.4% 1,515 76.0% 1.2% 2,163 68.8% 1.2%
Primary Diagnosis Non-Cholestatic Cirrhosis 309 89.3% 1.8% 309 82.5% 2.2% 785 75.0% 1.6% 1,058 67.2% 1.8%
Cholestatic Liver Disease/Cirrhosis 138 90.6% 2.5% 138 87.0% 2.9% 289 82.1% 2.4% 383 70.8% 3.3%
Acute Hepatic Necrosis 31 87.1% 6.0% 31 83.9% 6.6% 70 71.2% 5.4% 117 66.6% 4.4%
Biliary Atresia 60 95.0% 2.8% 60 93.3% 3.2% 140 83.5% 3.3% 243 78.5% 2.9%
Metabolic Diseases 15 73.3% 11.4% 15 60.0% 12.6% 40 60.0% 8.3% 69 65.3% 6.0%
Malignant Neoplasms 31 93.5% 4.4% 31 74.2% 7.9% 78 57.5% 6.3% 131 48.7% 5.2%
Other 55 90.9% 3.9% 55 87.3% 4.5% 113 80.6% 3.8% 162 77.1% 3.8%


Source: OPTN/SRTR Data as of May 1, 2006.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.

Medical urgency status codes have changed over time. See Technical Notes chapter for further information. footnote9